Go Pro

Agilent Technologies (A) Stock Forecast & Price Target

Agilent Technologies logo
$132.97 -3.04 (-2.23%)
Closing price 03:59 PM Eastern
Extended Trading
$132.87 -0.10 (-0.08%)
As of 07:56 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Agilent Technologies - Analysts' Recommendations and Stock Price Forecast (2026)

Consensus Rating

Sell
0
Hold
3
Buy
15

Based on 18 Wall Street analysts who have issued ratings for Agilent Technologies in the last 12 months, the stock has a consensus rating of "Moderate Buy." Out of the 18 analysts, 3 have given a hold rating, 13 have given a buy rating, and 2 have given a strong buy rating for A.

Consensus Price Target

$160.88
20.98% Upside
According to the 18 analysts' twelve-month price targets for Agilent Technologies, the average price target is $160.88. The highest price target for A is $185.00, while the lowest price target for A is $145.00. The average price target represents a forecasted upside of 20.98% from the current price of $132.97.
MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
Get the Latest News and Ratings for A and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for Agilent Technologies and its competitors.

Sign Up
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

A Analyst Ratings Over Time

TypeCurrent Forecast
6/29/25 to 6/29/26
1 Month Ago
5/30/25 to 5/30/26
3 Months Ago
3/31/25 to 3/31/26
1 Year Ago
6/29/24 to 6/29/25
Strong Buy
2 Strong Buy rating(s)
2 Strong Buy rating(s)
2 Strong Buy rating(s)
0 Strong Buy rating(s)
Buy
13 Buy rating(s)
13 Buy rating(s)
11 Buy rating(s)
7 Buy rating(s)
Hold
3 Hold rating(s)
1 Hold rating(s)
3 Hold rating(s)
6 Hold rating(s)
Sell
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
Consensus Price Target$160.88$160.93$161.20$140.92
Forecasted Upside20.98% Upside18.87% Upside41.52% Upside18.23% Upside
Consensus RatingModerate BuyBuyModerate BuyModerate Buy

A Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

A Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

Agilent Technologies Stock vs. The Competition

TypeAgilent TechnologiesMedical CompaniesBroader Market
Consensus Rating Score
2.94
2.29
2.52
Consensus RatingModerate BuyHoldModerate Buy
Predicted Upside19.33% Upside752.60% Upside14.34% Upside
News Sentiment Rating
Positive News

See Recent A News
Positive News
Positive News
DateBrokerageAnalystActionRatingPrice TargetReport Date
Upside/Downside
Details
6/26/2026
Eve Burstein
Eve Burstein
Not Rated
Initiated CoverageOutperform$155.00+14.20%
6/24/2026
Barclays PLC logo
Barclays
3 of 5 stars
Luke Sergott
Luke Sergott
4 of 5 stars
Boost TargetOverweight$145.00 ➝ $150.00+14.08%
6/11/2026
Piper Sandler logo
Piper Sandler
2 of 5 stars
David Westenberg
David Westenberg
4 of 5 stars
Initiated CoverageOverweightNeutral$150.00+13.74%
6/3/2026Lower TargetBuy$180.00 ➝ $165.00+19.02%
6/2/2026 UpgradeHold (C-)Hold (C)
6/2/2026Reiterated RatingHold
5/28/2026Boost TargetBuy$147.00 ➝ $155.00+14.32%
5/28/2026Lower TargetOverweight$165.00 ➝ $160.00+18.60%
5/28/2026UpgradeNeutralBuy$150.00 ➝ $145.00+25.20%
5/27/2026Initiated CoverageOutperform$153.00+32.70%
5/26/2026Boost TargetOutperform$155.00 ➝ $156.00+35.65%
3/3/2026Lower TargetOverweight$180.00 ➝ $160.00+38.13%
2/26/2026Lower TargetBuy$180.00 ➝ $165.00+38.94%
1/5/2026UpgradeIn-LineOutperform$155.00 ➝ $160.00+16.09%
12/9/2025Initiated CoverageBuy$170.00+19.43%
11/25/2025Boost TargetBuy$165.00 ➝ $185.00+17.40%
11/25/2025Boost TargetOverweight$165.00 ➝ $180.00+15.53%
10/8/2025 UpgradeStrong-Buy
5/30/2025 Boost TargetBuy$135.00+19.78%
4/21/2025Lower TargetHold$135.00 ➝ $116.00+16.44%
8/26/2024 Reiterated RatingBuy$151.00+7.19%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Monday at 08:55 PM ET.


Should I Buy Agilent Technologies Stock? A Pros and Cons Explained

These pros and cons were generated based on recent news and financial data from MarketBeat in order to provide readers with the fastest and most accurate insights. They were last updated on Saturday, June 27, 2026. Please send any questions or comments about these Agilent Technologies pros and cons to contact@marketbeat.com.

Agilent Technologies
Bull Case

green Wall Street bull icon

Here are some ways that investors could benefit from investing in Agilent Technologies, Inc.:

  • Agilent Technologies, Inc. has set its FY 2026 guidance at an EPS range of 6.000-6.100, indicating strong expected earnings growth which can attract investors looking for profitability.
  • The company recently announced a quarterly dividend of $0.255 per share, translating to an annualized dividend of $1.02, which provides a yield of approximately 0.7%. This can be appealing for income-focused investors.
  • Agilent Technologies, Inc. has a relatively low dividend payout ratio of 20.48%, suggesting that the company retains a significant portion of its earnings for reinvestment, which can support future growth.
  • The current stock price is around $720, reflecting the company's strong market position and investor confidence, which can be a positive indicator for potential investors.
  • With a focus on life sciences, diagnostics, and applied chemical markets, Agilent Technologies, Inc. is well-positioned in sectors that are expected to grow, making it an attractive option for long-term investment.

Agilent Technologies
Bear Case

red Wall Street bear icon

Investors should be bearish about investing in Agilent Technologies, Inc. for these reasons:

  • Despite the positive earnings guidance, the stock market can be volatile, and any unforeseen economic downturns could negatively impact Agilent Technologies, Inc.'s performance.
  • The dividend yield of 0.7% may be considered low compared to other investment opportunities, which could deter income-seeking investors.
  • Agilent Technologies, Inc. operates in highly competitive markets, and any loss of market share to competitors could adversely affect its profitability and stock performance.
  • Investors may be concerned about the company's reliance on regulatory compliance in its operations, as any changes in regulations could impact its business model and profitability.
  • Market analysts predict an EPS of 5.99 for the current fiscal year, which, while positive, may not meet the expectations of more aggressive growth investors.

A Forecast - Frequently Asked Questions

According to the research reports of 18 Wall Street equities research analysts, the average twelve-month stock price forecast for Agilent Technologies is $160.88, with a high forecast of $185.00 and a low forecast of $145.00.

18 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Agilent Technologies in the last twelve months. There are currently 3 hold ratings, 13 buy ratings and 2 strong buy ratings for the stock. The consensus among Wall Street analysts is that investors should "moderate buy" A shares.

According to analysts, Agilent Technologies's stock has a predicted upside of 20.98% based on their 12-month stock forecasts.

Over the previous 90 days, Agilent Technologies's stock had 3 upgrades by analysts.

Agilent Technologies has been rated by research analysts at Bank of America, Barclays, HSBC, Piper Sandler, Robert W. Baird, Royal Bank Of Canada, Sanford C. Bernstein, TD Cowen, Weiss Ratings, Wells Fargo & Company, and Wolfe Research in the past 90 days.

Analysts like Agilent Technologies more than other "medical" companies. The consensus rating for Agilent Technologies is Moderate Buy while the average consensus rating for "medical" companies is Hold. Learn more on how A compares to other companies.


This page (NYSE:A) was last updated on 6/29/2026 by MarketBeat.com Staff.
From Our Partners